NASDAQ$HQY
HealthEquity Inc · Q3 2025 earnings
Q3 2025 earnings · · Investor relations
Briefing
HealthEquity's third quarter performance in fiscal year 2025 showed strong growth in revenue, HSAs, and total accounts, driven by Team Purple's efforts and strategic investments.
HealthEquity reported a 21% increase in revenue to $300.4 million, with net income at $5.7 million and non-GAAP net income at $69.4 million. The company saw growth in HSAs to 9.5 million and total accounts to 16.5 million. They repurchased 0.7 million shares for $60 million and raised fiscal year 2025 guidance.
- Revenue increased by 21% to $300.4 million compared to Q3 FY24.
- HSAs grew to 9.5 million, a 15% increase year-over-year.
- Total accounts, including HSAs and CDBs, reached 16.5 million, up 8% from Q3 FY24.
- The company repurchased 0.7 million shares of its common stock for $60.0 million.
Headline financials
Revenue & EPS history
HealthEquity · Revenue · Quarterly
$300M
Revenue by segment
HealthEquity · $249M total across 3 segments · Q3 2024
- Service Revenue$108M-1.0%43.1%
- Custodial Revenue$107M+42.8%42.8%
- Interchange Revenue$35.1M+6.9%14.1%
Forward guidance
For the fiscal year ending January 31, 2025, HealthEquity anticipates revenue between $1.185 billion and $1.195 billion, net income of $88 million to $96 million ($0.99 to $1.08 per diluted share), non-GAAP net income of $274 million to $281 million ($3.08 to $3.16 per diluted share), and Adjusted EBITDA of $470 million to $480 million. For fiscal year 2026, they expect revenue of approximately $1.275 billion to $1.295 billion and Adjusted EBITDA of approximately 41.5% to 42.5% of revenue.
Tailwinds
- Revenue is expected to be between $1.185 billion and $1.195 billion.
- Net income is projected to be between $88 million and $96 million.
- Non-GAAP net income is anticipated to be between $274 million and $281 million.
- Adjusted EBITDA is expected to range from $470 million to $480 million.
- For fiscal year 2026, revenue is projected to be between $1.275 billion and $1.295 billion.
Headwinds
- Net income per diluted share is expected to be between $0.99 and $1.08.
- Non-GAAP net income per diluted share is projected to be between $3.08 and $3.16.
- Assumes an average annualized yield on HSA cash of approximately 3.4% to 3.5%.
- The net income outlook for fiscal year ending January 31, 2026 is not available without unreasonable efforts.
- Future cybersecurity breaches of technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-0.4%
Avg return
Earnings day
-1.9%
Avg return
5 days after
-1.1%
Avg return
30 days after
55%
29 / 53 earnings
Positive
+10.8%
Q1 2024
Best reaction
-22.2%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2027 | — | — | — | |
| Q4 2026 | +0.7% | +2.8% | +8.4% | |
| Q3 2026 | -2.9% | -5.5% | -7.7% | |
| Q2 2026 | +7.6% | +4.7% | -0.3% | |
| Q1 2026 | +9.1% | +7.1% | -1.5% | |
| Q4 2025 | -17.1% | -11.2% | -16.9% | |
| Q3 2025 | -4.8% | -4.6% | -0.5% | |
| Q2 2025 | +3.9% | -4.2% | -1.7% | |
| Q1 2025 | +2.1% | +4.4% | +2.3% | |
| Q4 2024 | -1.9% | -4.0% | -3.7% | |
| Q3 2024 | +0.4% | -0.8% | -0.7% | |
| Q2 2024 | +4.4% | +2.4% | +9.4% | |
| Q1 2024 | +10.8% | +9.4% | +6.1% | |
| Q4 2023 | +0.8% | -1.1% | +0.7% | |
| Q3 2023 | -2.3% | -7.7% | -9.8% | |
| Q2 2023 | +0.1% | +4.6% | +5.5% | |
| Q1 2023 | +2.0% | -0.0% | -4.8% | |
| Q4 2022 | +2.4% | +11.3% | +20.3% | |
| Q3 2022 | -21.3% | -24.8% | -14.4% | |
| Q2 2022 | +1.2% | -1.4% | -0.8% | |
| Q1 2022 | +0.4% | -3.2% | -1.6% | |
| Q4 2021 | -5.9% | -9.4% | -11.8% | |
| Q3 2021 | -3.7% | -8.5% | +8.1% | |
| Q2 2021 | +5.4% | -11.8% | -6.2% | |
| Q1 2021 | -6.6% | +5.9% | -5.6% | |
| Q4 2020 | -22.2% | -17.9% | -15.1% | |
| Q3 2020 | +2.9% | +9.6% | +17.4% | |
| Q2 2020 | -6.1% | -6.3% | -8.1% | |
| Q1 2020 | +1.7% | +6.0% | -0.4% | |
| Q4 2019 | +2.9% | -10.2% | -23.8% | |
| Q3 2019 | -17.5% | -23.8% | -38.8% | |
| Q2 2019 | +2.9% | +3.0% | -3.9% | |
| Q1 2019 | +4.8% | +4.6% | +1.1% | |
| Q4 2018 | +8.7% | +6.7% | +11.3% | |
| Q3 2018 | -5.8% | -6.4% | -1.7% | |
| Q2 2018 | +7.3% | +6.0% | +23.1% | |
| Q1 2018 | +8.8% | +7.4% | -0.2% | |
| Q4 2017 | -4.6% | -12.1% | -0.9% | |
| Q3 2017 | -1.1% | -2.4% | -2.8% | |
| Q2 2017 | +3.0% | -0.7% | +13.1% | |
| Q1 2017 | +7.9% | +7.4% | +11.7% | |
| Q4 2016 | +5.2% | — | — | |
| Q3 2016 | -4.6% | — | — | |
| Q2 2016 | +6.5% | — | — | |
| Q1 2015 | -0.1% | — | — | |
| Q1 2016 | +3.2% | — | — | |
| Q4 2013 | -0.1% | — | — | |
| Q1 2014 | -0.1% | — | — | |
| Q4 2015 | -1.0% | — | — | |
| Q3 2014 | -8.0% | — | — | |
| Q3 2015 | +0.7% | — | — | |
| Q2 2015 | -0.3% | — | — | |
| Q4 2014 | -0.3% | — | — | |
| Q2 2014 | -0.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro